Mosseri Marlio Charles's Form 4 filing
Nuvectis Pharma, Inc. (NVCT) · filed Jun 16, 2023
- Accession no.
- 0001104659-23-071869
- Filed
- Jun 16, 2023
- Trade date
- Jun 15, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $568.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mosseri Marlio CharlesCIK 0001806384 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2023 | Common Stock | PPurchaseAcquired | +400 | $17.54 | +$7,016 | 2,380,576 | Direct | |
| Jun 15, 2023 | Common Stock | PPurchaseAcquired | +31,724 | $17.71 | +$561,832.04 | 2,412,300 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.